Asianet Newsable on MSN
HeartBeam announces first patient enrollments in heart attack detection pilot study
HeartBeam’s technology uniquely capable of assessing possible heart attacks outside of traditional clinical settings ALIGN-ACS study expected to complete patient enrollment quickly Milestone signifies ...
From the Oura Ring to the Apple Watch to the Google Pixel — here's what the science really says about the accuracy of their health data ...
Stellar Resources’ latest drilling has hit a new high-grade tin lode 60m below the Severn resource at its Heemskirk project in Tasmania. The project hosts a resource of 9.5 Mt @ 0.93% tin for 88,100t ...
New research was motivated by "high-potential societal impacts" of successfully disabling autonomous drones, a study author ...
Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...
President Trump, in a rally-like speech in Kentucky, stressed familiar talking points on the economy, highlighting tax cuts ...
Kingsland Minerals’ metallurgical drilling delivers strong graphite assays topping at 125.6m at 10.1% TGC from Leliyn in the NT. ... Read More The post Kingsland drilling delivers high-grade graphite ...
Leidos Holdings has been on an acquisition spree while also achieving impressive margins and new contract wins. Read why LDOS ...
Study data from patients with relapsed or refractory gynecologic cancers signals the potential of LYMPHIR to augment immune checkpoint inhibitor efficacy Topline data ...
It's later in the evening. The Bemidji State men's hockey team's practice has concluded. Players have retreated to their homes or dorm rooms. Tory Lund can be found in a familiar setting. The Beavers' ...
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or "off the shelf", cell therapies for serious medical conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results